This trial is studying a better way to treat women who have hot flashes after menopause.
- Hot Flashes
4 Primary · 6 Secondary · Reporting Duration: Baseline to Week 26
Side Effects for
2 Treatment Groups
1 of 2
Placebo + elinzanetant
1 of 2
370 Total Participants · 2 Treatment Groups
Primary Treatment: Elinzanetant (BAY3427080) · Has Placebo Group · Phase 3
Who is running the clinical trial?
Age 40 - 65 · Female Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
How old are they?
|18 - 65||100.0%|
What site did they apply to?
|St. Vincent's Hospital - Birmingham||20.0%|
|Soapstone Center for Clinical Research||20.0%|
|Houston Center for Clinical Research, LLC||40.0%|
What portion of applicants met pre-screening criteria?
|Did not meet criteria||28.6%|
- 2021. "A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05042362.
Frequently Asked Questions
How many research facilities are in charge of this experiment?
"Among other locations, this study is occurring at Essential Women's Health Associates in Las Vegas, Nevada, Investigators Research Group, LLC in Brownsburg, Indiana, and Maximos Ob/Gyn in League City, Texas." - Anonymous Online Contributor
How can I enroll myself in this research project?
"This trial is looking for 370 patients that are experiencing hot flashes and are between 40-65 years old. Additionally, the potential participants must have completed the Hot Flash Daily Diary for at least 11 days in the two weeks before the baseline visit. They must also have recorded at least 50 moderate or severe hot flashes in the last 7 days of the HFDD." - Anonymous Online Contributor
Are people still being taken on as participants for this research project?
"Yes, the data on clinicaltrials.gov indicates that this study is actively searching for candidates. The trial was initially posted on 8/27/2021 and was last updated on 10/31/2022. The study is searching for 370 patients at 58 locations." - Anonymous Online Contributor
Are elderly patients being accepted for this clinical trial?
"The minimum age requirement for this study is 40 years old and the maximum is 65 years old." - Anonymous Online Contributor
What kind of health risks are associated with taking Elinzanetant?
"Elinzanetant (BAY3427080) is in Phase 3 of clinical trials, which means that there is both some efficacy data and multiple rounds of safety data. Therefore, it received a score of 3." - Anonymous Online Contributor